$33.12+43.94% · 3M
Moving avg
1W+16.83%
1M+20.88%
3M+43.94%
6M+50.55%
YTD+50.55%
1Y+50.55%
3Y+50.55%
5Y+50.55%
52-week range
$18.8572% of range$38.54
Company health
Value0/6
Growth0/6
Profitability2/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- High return on equity (42855%)
Risks
- Currently unprofitable
- Burning free cash flow
Key statistics
Valuation
Market cap
$2.30B
Enterprise value
$2.45B
P/E ratio (TTM)
-69.00x
P/S ratio (TTM)
45.70x
EV/EBITDA
-74.33x
Per share & returns
EPS (TTM)
-$0.10
Dividend yield
0.00%
Beta (1Y)
-6.18
30-day change
+20.88%
Trading
Volume (24h)
558.00K
Previous close
$36.57
Shares outstanding
69.31M
About Alamar Biosciences, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
ALMR
Alamar Biosciences, Inc. is a mid-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker ALMR.
Frequently asked questions
What is Alamar Biosciences, Inc.'s market cap?
Alamar Biosciences, Inc. (ALMR) has a market capitalization of $2.30B.
What sector is Alamar Biosciences, Inc. in?
Alamar Biosciences, Inc. operates in the Healthcare sector, Biotechnology industry.
What exchange does ALMR trade on?
ALMR trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap